The Journal of Neuroscience, 2018 · DOI: 10.1523/JNEUROSCI.0585-18.2018 · Published: October 24, 2018
Remyelination failure in chronic demyelinating diseases such as multiple sclerosis drives the current quest for developing means by which remyelination in CNS can be enhanced therapeutically. Critical to this endeavor is the need to understand the mechanisms of remyelination, including the nature and identity of the cells capable of generating new myelin sheath-forming cells. Here, we report a previously unrecognized subpopulation of nonmyelinating Schwann cells (SCs) in the PNS, identified by the expression of the transcription factor Foxj1, which can give rise to SCs that are capable of remyelinating both PNS and CNS axons.
Foxj1-expressing nonmyelinating Schwann cells represent a new cellular target for myelin regenerative strategies.
Further research into the mechanisms by which Foxj1+ NMSCs contribute to remyelination can lead to more effective therapies.
These cells therefore represent a new cellular target for myelin regenerative strategies for the treatment of CNS disorders characterized by persistent demyelination.